Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating safety and pharmacology of the PI3-kinase inhibitor pictilisib (GDC-0941) in combination with chemotherapy regimens…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation [Phase 3]
Phase 3 study evaluating Onartuzumab with Erlotinib in MET-positive, EGFR-mutant non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy
This observational study update reports outcomes for patients with non-small cell lung cancer who achieved long progression-free survival af…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the safety and pharmacology of GDC-0941 in combination with erlotinib in patients with advanced solid tumors, inclu…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung Cancer [Phase 2]
The document reports the completion of a Phase 2 exploratory trial evaluating RO4929097 in patients with recurrent or refractory non-squamou…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung) [Phase 3]
A Phase 3 clinical trial evaluating onartuzumab in combination with erlotinib (Tarceva) in patients with Met diagnostic-positive non-small c…
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Routine Practice For First Line Maintenance Therapy in Patients With Non Small Cell Lung Cancer
This document reports an observational study evaluating Tarceva (erlotinib) as first-line maintenance therapy in routine practice for patien…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
The PEPITA observational study evaluating erlotinib (Tarceva) in second-line squamous non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer
An observational study evaluating Tarceva (erlotinib) in patients with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of Lung Cancer Related Symptoms and Disease Control Rate in Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Chemotherapy With or Without Avastin (Bevacizumab)
An observational study evaluating lung cancer-related symptoms and disease-control rate in patients with non-squamous non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. [Phase 2]
A genetic substudy associated with Roche's Avastin trial MO19390 in advanced or recurrent non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer. [Phase 1]
Phase 1 feasibility trial evaluating Avastin (bevacizumab) with concomitant chemoradiation (cisplatin and vinorelbine) for locally advanced …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)
This update covers a completed observational study evaluating erlotinib (Tarceva) in previously treated patients with advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics
This is a completed non-interventional study sponsored by Hoffmann-La Roche that assesses the occurrence rates of several cancers in Turkey …
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)
An observational study update assessing first-line erlotinib (Tarceva) in advanced EGFR mutation-positive non-small cell lung cancer (GERTAC…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer
This entry reports a completed observational study evaluating Avastin (bevacizumab) in combination with chemotherapy for metastatic or recur…
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Clinical trial update examining dynamic changes of circulating tumor DNA in patients with late-stage non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: ADAM-Afatinib Diarrhea Assessment and Management [Phase 3]
This Phase 3 trial update reports on the incidence and management of diarrhea associated with afatinib in patients with non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial update reports the completion of evaluating Erlotinib hydrochloride in combination with Quinacrine dihydrochloride …
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Imaging With 11C-erlotinib PET/CT to Identify Responders to Erlotinib Treatment in NSCLC [NA]
This clinical trial update describes using PET/CT imaging with 11C-erlotinib to identify which non-small cell lung cancer patients respond t…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery [Phase 2]
Phase 2 clinical trial evaluating stereotactic body radiation therapy for patients with stage I or II non-small cell lung cancer resectable …
-
CLINICAL_TRIALS research · 2016-10-27Clinical Trial Update: ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC
This clinical trial update covers ALK, ROS1, and MET mutations detected in plasma ctDNA from non-small cell lung cancer patients, including …
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial update for Sym004 in stage IV non-small cell lung cancer. The study was terminated and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing BCD-021 with paclitaxel and carboplatin to Avastin with paclitaxel and carboplatin in non-small cell lung cancer has…
-
CLINICAL_TRIALS research · 2016-10-24Clinical Trial Update: Micro RNA Genetic Signature in NSCLC Egyptian Patients
A clinical trial evaluating microRNA genetic signatures in Egyptian patients with non-small cell lung cancer has completed.